|
Free Research Articles
Citations 221-230 of 789 total displayed.
|
Past content
(since May 2004):
|
Solid cancers after allogeneic hematopoietic cell transplantation
- J. Douglas Rizzo, Rochelle E. Curtis, Gérard Socié, Kathleen A. Sobocinski, Ethel Gilbert, Ola Landgren, Lois B. Travis, William D. Travis, Mary E. D. Flowers, Debra L. Friedman, Mary M. Horowitz, John R. Wingard, and H. Joachim Deeg
Blood 2009; 113: 1175-1183.
[Abstract]
[Full text]
[PDF]
Life after the thymus: CD31+ and CD31– human naive CD4+ T-cell subsets
- Siegfried Kohler and Andreas Thiel
Blood 2009; 113: 769-774.
[Abstract]
[Full text]
[PDF]
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors
- Pau Montesinos, Juan M. Bergua, Edo Vellenga, Chelo Rayón, Ricardo Parody, Javier de la Serna, Angel León, Jordi Esteve, Gustavo Milone, Guillermo Debén, Concha Rivas, Marcos González, Mar Tormo, Joaquín Díaz-Mediavilla, Jose D. González, Silvia Negri, Elena Amutio, Salut Brunet, Bob Lowenberg, and Miguel A. Sanz
Blood 2009; 113: 775-783.
[Abstract]
[Full text]
[PDF]
The largest prospective warfarin-treated cohort supports genetic forecasting
- Mia Wadelius, Leslie Y. Chen, Jonatan D. Lindh, Niclas Eriksson, Mohammed J. R. Ghori, Suzannah Bumpstead, Lennart Holm, Ralph McGinnis, Anders Rane, and Panos Deloukas
Blood 2009; 113: 784-792.
[Abstract]
[Full text]
[PDF]
Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group–directed intergroup trial S9003
- Madhav V. Dhodapkar, Antje Hoering, Morie A. Gertz, Saul Rivkin, Jackie Szymonifka, John Crowley, and Bart Barlogie
Blood 2009; 113: 793-796.
[Abstract]
[Full text]
[PDF]
Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia
- Pamela S. Becker, Kenneth J. Kopecky, Adrianne N. Wilks, Sylvia Chien, John M. Harlan, Cheryl L. Willman, Stephen H. Petersdorf, Derek L. Stirewalt, Thalia Papayannopoulou, and Frederick R. Appelbaum
Blood 2009; 113: 866-874.
[Abstract]
[Full text]
[PDF]
Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients
- Augusto B. Federici, Pier M. Mannucci, Giancarlo Castaman, Luciano Baronciani, Paolo Bucciarelli, Maria T. Canciani, Alessandro Pecci, Peter J. Lenting, and Philip G. De Groot
Blood 2009; 113: 526-534.
[Abstract]
[Full text]
[PDF]
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab
- Farrukh T. Awan, Neil E. Kay, Melanie E. Davis, Wenting Wu, Susan M. Geyer, Nelson Leung, Diane F. Jelinek, Renee C. Tschumper, Charla R. Secreto, Thomas S. Lin, Michael R. Grever, Tait D. Shanafelt, Clive S. Zent, Timothy G. Call, Nyla A. Heerema, Gerard Lozanski, John C. Byrd, and David M. Lucas
Blood 2009; 113: 535-537.
[Abstract]
[Full text]
[PDF]
Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency
- Éva Ajzner, Ágota Schlammadinger, Adrienne Kerényi, Zsuzsanna Bereczky, Éva Katona, Gizella Haramura, Zoltán Boda, and László Muszbek
Blood 2009; 113: 723-725.
[Abstract]
[Full text]
[PDF]
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
- Sarah Cooley, Elizabeth Trachtenberg, Tracy L. Bergemann, Koy Saeteurn, John Klein, Chap T. Le, Steven G. E. Marsh, Lisbeth A. Guethlein, Peter Parham, Jeffrey S. Miller, and Daniel J. Weisdorf
Blood 2009; 113: 726-732.
[Abstract]
[Full text]
[PDF]
|
|
